Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population
Abstract Background NAD (P) H: quinone oxidoreductase (1) (NQO1‐HGNC: 2874) and myeloperoxidase (MPO‐HGNC: 7218) are two enzymes involved in phase II of the xenobiotic metabolism pathway. Methods In this study, a case–control analysis was conducted to investigate the relationship between genetic var...
Guardado en:
Autores principales: | Imen Hemissi, Haroun Ayed, Zeineb Naimi, Khedija Meddeb, Mouna Ayadi, Skander Zouari, Selim Zaghbib, Emna Talbi, Mohamed Chebil, Slah Ouerhani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e85fafc44e84500819fd38f83b14ce0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
4NQO Carcinogenesis: A Model of Oral Squamous Cell Carcinoma
por: Rivera Martínez,César Andrés
Publicado: (2012) -
NQO1 Enzyme and its Role in Cellular Protection; an Insight
por: Ahmed Atia, et al.
Publicado: (2020) -
Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence
por: Huan Liu, et al.
Publicado: (2021) -
Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy
por: Bhargav Shreevatsa, et al.
Publicado: (2021) -
Suppression of L-Arginine-Induced Acute Necrotizing Pancreatitis in Rats by Metformin Associated with the Inhibition of Myeloperoxidase and Activation of Interleukin-10
por: Al-Hashem,Fahaid
Publicado: (2021)